Related Experiment Video
Updated: Dec 11, 2025
06:15
Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
Published on: October 27, 2014
27.7K
Abstract:
A mouse study suggests that daily doses of a CSF1R inhibitor after radiation therapy can reduce the likelihood of glioblastoma recurrence. Mice that received the inhibitor lived more than twice as long as control animals, and only 20% of them developed recurrent tumors, whereas all control animals did.
Insights
Daily CSF1R inhibitor doses after radiation therapy significantly reduced glioblastoma recurrence in mice. Treated mice lived twice as long, with fewer tumors, suggesting a promising therapeutic strategy for brain cancer.
Area of Science:
- Neuro-oncology
- Cancer Biology
- Radiotherapy Research
Background:
- Glioblastoma is an aggressive brain tumor with high recurrence rates.
- Current treatments include surgery, radiation, and chemotherapy, often with limited success.
- Understanding glioblastoma recurrence mechanisms is crucial for developing novel therapies.
Discussion:
- This study investigated the efficacy of a Colony-Stimulating Factor 1 Receptor (CSF1R) inhibitor in preventing glioblastoma recurrence post-radiation.
- Mice receiving daily CSF1R inhibitor doses post-radiation exhibited significantly longer survival.
- A notable reduction in tumor recurrence was observed in the inhibitor group compared to controls.
Key Insights:
- CSF1R inhibition following radiation therapy markedly decreased glioblastoma recurrence in a preclinical mouse model.
- Mice treated with the CSF1R inhibitor demonstrated more than double the lifespan of control animals.
- Tumor recurrence was observed in only 20% of inhibitor-treated mice, versus 100% in controls.
Outlook:
- CSF1R inhibitors represent a potential therapeutic avenue to improve outcomes for glioblastoma patients.
- Further research is warranted to translate these findings into clinical applications.
- Combination therapies involving CSF1R inhibitors and radiation may offer synergistic benefits.
